Silvy Collin defended her dissertation at the Donders Institute on 12 October 2018 and was awarded her PhD. During her time in our lab, Silvy worked on the representations of episodic memories using fMRI. Silvy is now a postdoc in Ken Norman’s Computational Memory lab at Princeton.
Our new primer article on Alzheimer’s disease and potential new biomarkers is out now on Current Biology.
Humans differ from other primates through their superior intellectual and mental abilities. When a gradual and chronic loss of these cognitive functions leads to a loss of independent living, the individual is described as being demented. Such declining cognitive functions encompass all mental processes involved in acquiring knowledge and practical skills, including memory, language, reasoning and attention. Today, Alzheimer’s disease is the most prevalent neurodegenerative disorder, comprising approximately 60% of dementia cases. With steadily improving standards of living, people in developed regions of the world are living longer, and Alzheimer’s disease is associated strongly with old age. The number of cases of Alzheimer’s disease has been increasing steadily, and with today’s aging population, the number of people with dementia worldwide is expected to quadruple by 2050 unless effective treatment or prevention becomes available. In this Primer, we consider the symptoms, biological basis and potential biomarkers of Alzheimer’s disease.
Silvy Collin has been awarded the Rubicon grant by The Netherlands Organisation for Scientific Research (NWO) to continue her scientific career at the Princeton Computational Neuroscience lab lead by Ken Norman. During her postdoc there she wants to investigate how the brain structures continuous, real-life experience with the use of computational modeling, neuroimaging and realistic episodic memory tasks. We wish Silvy all the best for her future!
Read more on the NWO website.